SCHEULE 13D / CELL THERAPEUTICS, INC.

Company

JOHNSON & JOHNSON

Filed

November 6, 1997

Accession Number

0000950123-97-009182

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →